微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 11.01% | 25.26% | 240.87% | 20/159 | 1.21% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | 3.23% | -38.83% | 42.92% | 59/159 | 0.26% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | 2.26% | -33.92% | -70.84% | 48/159 | -0.37% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | 7.75% | -32.67% | -11.83% | 42/159 | -9.52% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | 8.79% | -6.89% | 66.48% | 35/159 | 4.23% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 5.28% | -16.59% | 54.39% | 34/159 | 2.66% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 3.42% | 12.5% | -70.29% | 23/159 | 2.32% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 11.51% | 9.72% | 21.93% | 24/159 | -1.03% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 9.44% | 14.42% | 49.13% | 26/159 | 2.34% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 6.33% | 31.06% | 108.22% | 24/159 | 1.46% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 3.04% | 33.33% | -71.02% | 35/159 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 10.49% | -24.37% | 27.15% | 43/159 | 0.67% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 8.25% | -31.25% | 70.81% | 45/159 | 2.8% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 4.83% | -43.51% | 111.84% | 49/159 | 2.16% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 2.28% | -41.39% | -83.56% | 52/159 | 1.57% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 13.87% | -34.64% | 15.58% | 24/159 | 0.75% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 12% | 2% | 40.35% | 22/159 | 4.43% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 8.55% | -3.82% | 119.79% | 20/159 | 2.94% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 3.89% | 2% | -81.67% | 21/159 | 2.49% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 21.22% | -2.57% | 138.7% | 17/159 | 3.58% | 哈三联 | 27.17% | 行业排名> |
| 2020-06-30 | 8.89% | 2% | -59.18% | 26/159 | 4.19% | 汇宇制药 | 55.94% | 行业排名> |
| 2019-12-31 | 21.78% | 38.64% | 38.64% | 17/159 | 2.53% | 河化股份 | 45.32% | 行业排名> |
| 2018-12-31 | 15.71% | 31.14% | 31.14% | 27/159 | 6.99% | 汇宇制药 | 31.9% | 行业排名> |
| 2017-12-31 | 11.98% | 2% | 2% | 40/159 | 9.61% | 誉衡药业 | 35.56% | 行业排名> |